full-text guidelines incorporating the updated material are available on the Internet (www.
acc. org or www. americanheart. org) in both a version that shows the changes from the …

There are over 1.3 million known diabetic patients in the UK and a similar number who have
the disease undiagnosed. Over 90% have non-insulin dependent diabetes mellitus usually …

ContextMany patients with chronic angina experience anginal episodes despite
revascularization and antianginal medications. In a previous trial, antianginal monotherapy …

Objectives: The primary objective of the Monotherapy Assessment of Ranolazine In Stable
Angina (MARISA) trial was to determine the dose-response relationship of ranolazine, a …

Objectives: We sought to evaluate the relative efficacies of three possible therapeutic
strategies for patients with multivessel coronary artery disease (CAD), stable angina, and …

Background Drug-eluting stents (DES) are associated with lower restenosis rates than bare-
metal stents (BMS), but the benefits and safety of the new devices have not been …

Background—Sirolimus reduces acute rejection in renal transplant recipients and prevents
vasculopathy in nonhuman primates and in-stent restenosis in humans. Its effects on …

BACKGROUND: The optimal percutaneous interventional strategy for dealing with
significant non-culprit lesions in patients with multivessel disease (MVD) with acute …

Background—Although most randomized clinical trials have suggested that long-term
survival rates after percutaneous coronary intervention (PCI) or surgical multivessel …

Background—Restenosis and consequent adverse cardiac events are increased in
diabetics undergoing percutaneous coronary intervention. Use of intracoronary stents may …